These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7282221

  • 1. Kainic acid induced lesion of ventral tegmental area: locomotor effect of apomorphine.
    Morgenstern R.
    Acta Biol Med Ger; 1980; 39(8-9):911-5. PubMed ID: 7282221
    [Abstract] [Full Text] [Related]

  • 2. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z, Turski L, Wawrzyniak M, Cybulska R.
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [Abstract] [Full Text] [Related]

  • 3. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 4. Small doses of apomorphine and chronic administration of d-amphetamine reduce locomotor hyperactivity produced by radiofrequency lesions of dopaminergic A10 neurons area.
    Stinus L, Gaffori O, Simon H, Le Moal M.
    Biol Psychiatry; 1977 Dec; 12(6):719-32. PubMed ID: 563741
    [Abstract] [Full Text] [Related]

  • 5. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM, Nurk AM.
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [Abstract] [Full Text] [Related]

  • 6. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H, Morgenstern R.
    Acta Biol Med Ger; 1980 Nov; 39(8-9):903-10. PubMed ID: 7282220
    [Abstract] [Full Text] [Related]

  • 7. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ, Bunney EB, Zigun JR, Skirboll LR, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
    Parry TJ, Eberle-Wang K, Lucki I, Chesselet MF.
    Exp Neurol; 1994 Aug; 128(2):181-90. PubMed ID: 7915675
    [Abstract] [Full Text] [Related]

  • 13. The locomotor and exploratory activities in rats after lesion of hippocampal pyramidal cells with kainic acid.
    Kleinrok Z, Turski L, Wawrzyniak M, Cybaulska R.
    Pol J Pharmacol Pharm; 1980 Aug; 32(5):625-37. PubMed ID: 6115368
    [Abstract] [Full Text] [Related]

  • 14. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 15. Effect of kainic acid on striatal dopamine receptors.
    Weinreich P, Seeman P.
    Brain Res; 1980 Oct 06; 198(2):491-6. PubMed ID: 7407614
    [No Abstract] [Full Text] [Related]

  • 16. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 06; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A, Havemann-Reinecke U.
    J Neural Transm Suppl; 1995 Jan 06; 45():143-55. PubMed ID: 8748620
    [Abstract] [Full Text] [Related]

  • 20. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms.
    Braga PQ, Dias FR, Carey RJ, Carrera MP.
    Behav Brain Res; 2009 Dec 01; 204(1):169-74. PubMed ID: 19520118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.